Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancer
Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancer
Background
Measures of prognosis for cancer patients are typically evaluated at the time of diagnosis. However, this study assessed the changes in 2-year CS rates after first-line chemotherapy for metastatic UC.
Patients and Methods
Conditional overall survival and CPFS probability were estimated using the Kaplan–Meier method. Adjusted survival functions were stratified according to age groups (< 70 years vs. ? 70 years), sex, Eastern Cooperative Oncology Group (ECOG) performance status (PS; ECOG PS ? 2 vs. ECOG PS > 2), pretreatment Hb levels (< 12 mg/dL vs. ? 12 mg/dL) and pretreatment NLR (< 3 vs. ? 3). Pairs of CS curves were compared using the Mantel–Haenszel log-rank test.
Results
Two hundred ninety-eight patients were included in this analysis, 233 were male, and their median age was 69 years. First-line median overall survival and progression-free survival were 10.7 months (95% confidence interval [CI], 9.6-12.6) and 6.0 months (95% CI, 5.5-7.1), respectively. CPFS and COS showed an increasing trend in the population considered (b = 0.35; P < .001 and b = 0.79; P < .001, respectively). A significant increase in terms of COS and CPFS trends was identified in patients with age < 70 years (P = .02 and P = .005, respectively) and pretreatment NLR ? 3 (P = .05 and P < .001, respectively). Patients with Hb levels < 12 g/dL showed a significantly poorer 2-year COS.
Conclusion
The conditional probability of survival at 2 years from the start of first-line chemotherapy for advanced UC changes over time according to clinical characteristics.
advanced urothelial cancer, conditional survival, overall survival, prognosis, progression-free survival
1-6
Santoni, Matteo
317ff6c0-4762-4111-926d-463f2b0a5faf
Crabb, Simon J.
bcd1b566-7677-4f81-8429-3ab0e85f8373
Conti, Alessandro
56b7fd84-c28e-490f-827f-d33d7aa35801
Rossi, Lorena
2cb398a3-65e0-4aad-bab6-d7c0c49da2d5
Burattini, Luciano
f342ffa8-7d20-44b8-9664-a30d3eab8031
Conteduca, Vincenza
080e2568-d951-455f-8268-2ad478c555f1
Chau, Caroline
eee5b8a2-0843-432c-9f3a-abbe6e6e23f4
Burgio, Salvatore L.
280652dd-5e6a-4ad5-a969-83613b606c2e
Muzzonigro, Giovanni
94ee63b2-b0b1-4b6c-afcd-b1f4698220df
Cascinu, Stefano
dd75ee6d-d9f8-4ac7-a49a-d57f1a0cc0f6
De Giorgi, Ugo
86c9f3a7-1680-4a3f-a34f-32cab5d47b4f
24 October 2014
Santoni, Matteo
317ff6c0-4762-4111-926d-463f2b0a5faf
Crabb, Simon J.
bcd1b566-7677-4f81-8429-3ab0e85f8373
Conti, Alessandro
56b7fd84-c28e-490f-827f-d33d7aa35801
Rossi, Lorena
2cb398a3-65e0-4aad-bab6-d7c0c49da2d5
Burattini, Luciano
f342ffa8-7d20-44b8-9664-a30d3eab8031
Conteduca, Vincenza
080e2568-d951-455f-8268-2ad478c555f1
Chau, Caroline
eee5b8a2-0843-432c-9f3a-abbe6e6e23f4
Burgio, Salvatore L.
280652dd-5e6a-4ad5-a969-83613b606c2e
Muzzonigro, Giovanni
94ee63b2-b0b1-4b6c-afcd-b1f4698220df
Cascinu, Stefano
dd75ee6d-d9f8-4ac7-a49a-d57f1a0cc0f6
De Giorgi, Ugo
86c9f3a7-1680-4a3f-a34f-32cab5d47b4f
Santoni, Matteo, Crabb, Simon J., Conti, Alessandro, Rossi, Lorena, Burattini, Luciano, Conteduca, Vincenza, Chau, Caroline, Burgio, Salvatore L., Muzzonigro, Giovanni, Cascinu, Stefano and De Giorgi, Ugo
(2014)
Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancer.
Clinical Genitourinary Cancer, .
(doi:10.1016/j.clgc.2014.10.003).
(PMID:25465492)
Abstract
Background
Measures of prognosis for cancer patients are typically evaluated at the time of diagnosis. However, this study assessed the changes in 2-year CS rates after first-line chemotherapy for metastatic UC.
Patients and Methods
Conditional overall survival and CPFS probability were estimated using the Kaplan–Meier method. Adjusted survival functions were stratified according to age groups (< 70 years vs. ? 70 years), sex, Eastern Cooperative Oncology Group (ECOG) performance status (PS; ECOG PS ? 2 vs. ECOG PS > 2), pretreatment Hb levels (< 12 mg/dL vs. ? 12 mg/dL) and pretreatment NLR (< 3 vs. ? 3). Pairs of CS curves were compared using the Mantel–Haenszel log-rank test.
Results
Two hundred ninety-eight patients were included in this analysis, 233 were male, and their median age was 69 years. First-line median overall survival and progression-free survival were 10.7 months (95% confidence interval [CI], 9.6-12.6) and 6.0 months (95% CI, 5.5-7.1), respectively. CPFS and COS showed an increasing trend in the population considered (b = 0.35; P < .001 and b = 0.79; P < .001, respectively). A significant increase in terms of COS and CPFS trends was identified in patients with age < 70 years (P = .02 and P = .005, respectively) and pretreatment NLR ? 3 (P = .05 and P < .001, respectively). Patients with Hb levels < 12 g/dL showed a significantly poorer 2-year COS.
Conclusion
The conditional probability of survival at 2 years from the start of first-line chemotherapy for advanced UC changes over time according to clinical characteristics.
This record has no associated files available for download.
More information
Published date: 24 October 2014
Keywords:
advanced urothelial cancer, conditional survival, overall survival, prognosis, progression-free survival
Organisations:
Cancer Sciences
Identifiers
Local EPrints ID: 372463
URI: http://eprints.soton.ac.uk/id/eprint/372463
ISSN: 1558-7673
PURE UUID: 4be2e1d0-737c-4228-9557-6a4a33b8f8e0
Catalogue record
Date deposited: 15 Dec 2014 12:32
Last modified: 15 Mar 2024 03:16
Export record
Altmetrics
Contributors
Author:
Matteo Santoni
Author:
Alessandro Conti
Author:
Lorena Rossi
Author:
Luciano Burattini
Author:
Vincenza Conteduca
Author:
Caroline Chau
Author:
Salvatore L. Burgio
Author:
Giovanni Muzzonigro
Author:
Stefano Cascinu
Author:
Ugo De Giorgi
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics